Wired for What’s Next.
Reach your press release and disclosure targets.
Get more views with multimedia.
Track your results and refine your message.
Be the news everyone talks about.
Latest News
Today is June 04, 2023.
All times in Eastern Daylight Time.
-
VITRAC Therapeutics to Present Phase 1 Clinical Trial Design on Novel Aurora Kinase A Inhibitor, VIC-1911, and G12C Inhibitor, Sotorasib, for KRAS G12C-Mutant Non-Small Cell Lung Cancer at the 2023 ASCO Annual Meeting
BOSTON--(BUSINESS WIRE)--VITRAC Therapeutics, LLC (VITRAC) presented a poster on the Phase 1a/1b clinical trial of aurora kinase A (AURKA) inhibitor, VIC-1911, as monotherapy and in combination wit... more » -
Cyxtera Takes Next Step to Implement Restructuring Support Agreement
MIAMI--(BUSINESS WIRE)--Cyxtera (NASDAQ: CYXT), a global leader in data center colocation and interconnection services, today announced that, pursuant to the previously disclosed Restructuring Supp... more » -
Walkinshaw Andretti United Selects Stratasys FDM as Its 3D Printing Technology of Choice
CLAYTON, Australia--(BUSINESS WIRE)--Stratasys Ltd. (NASDAQ: SSYS), a leader in polymer 3D printing solutions, and Australia channel partner TCL Hofmann announced that motorsports team Walkinshaw A... more » -
Natera Announces Data from the ProActive Study that Supports Prospera™ Kidney as an Early Indicator of Transplant Rejection
AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced new data on its Prospera test being presented at the American Transplant Congr... more » -
Blue Yonder and nConnect Group Successfully Implement WMS Solution for Team Global Express in New Zealand
MELBOURNE, Australia & SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Team Global Express, Australia and New Zealand’s leading multi-modal logistics provider, has digitally transformed its warehousing capabil... more » -
BrainChip and Lorser Industries to Develop Neuromorphic Computing Systems for Software-Defined Radio Devices
LAGUNA HILLS, Calif.--(BUSINESS WIRE)--BrainChip and Lorser Industries to Develop Neuromorphic Computing Systems for Software-Defined Radio Devices more » -
Relay Robotics Introduces Relay2, The New High-Capacity Hotel Delivery Robot
NEW YORK & CAMPBELL, Calif.--(BUSINESS WIRE)--Relay Robotics, a leading manufacturer of autonomous service robots to the hospitality industry, introduces its newest hotel robot today, Relay2. more » -
Reigniting the Cancer Moonshot: Massive Bio Joins CancerX as Founding Member to Accelerate Innovation and AI Implementation in Cancer Care
NEW YORK--(BUSINESS WIRE)--Massive Bio, a globally recognized leader in the oncology space, has proudly announced its appointment as a founding member of CancerX, a groundbreaking initiative endors... more » -
Research Results from Ontada HOPE Studies Presented at ASCO 2023 Illuminate How Social Determinants of Health Impact Different Patient Populations with Triple-Negative Breast Cancer
BOSTON--(BUSINESS WIRE)--Ontada presented new data at ASCO 2023 focused on social determinants of health (SDOH) and real-world outcomes for patients with metastatic NSCLC. more » -
Puma Biotechnology Announces Presentation of Biomarker Findings from a Phase II Study of Alisertib with Paclitaxel versus Paclitaxel Alone in Metastatic or Locally Recurrent Breast Cancer at the 2023 ASCO Annual Meeting
LOS ANGELES--(BUSINESS WIRE)--Biomarker findings from a P II study of alisertib+paclitaxel v. paclitaxel alone in met. HR+ and triple neg breast cancer were presented at ASCO 2023 more » -
Four-Year Outcomes from Phase 3 CheckMate -9LA Trial Show Durable, Long-Term Survival with Opdivo (nivolumab) Plus Yervoy (ipilimumab) with Two Cycles of Chemotherapy for Patients with Metastatic Non-Small Cell Lung Cancer
PRINCETON, N.J.--(BUSINESS WIRE)--Four-Year Outcomes from Phase 3 CheckMate -9LA Trial Show Durable, Long-Term Survival with Opdivo (nivolumab) Plus Yervoy (ipilimumab) with..... more » -
Nucleai and Mayo Clinic BioPharma Diagnostics Announce Strategic Collaboration to Transform Digital Pathology for Drug Development and Clinical Practice
CHICAGO--(BUSINESS WIRE)--Nucleai, a leading provider of artificial intelligence (AI) solutions for pathology and spatial biology, and Mayo Clinic BioPharma Diagnostics are pleased to announce a st... more » -
TAGRISSO® achieved unprecedented survival in early-stage EGFR-mutated lung cancer, with 88% of patients alive at five years in ADAURA Phase III trial
WILMINGTON, Del.--(BUSINESS WIRE)--Positive results from the ADAURA Phase III trial showed AstraZeneca’s TAGRISSO® (osimertinib) demonstrated a statistically significant and clinically meaningful i... more » -
ELAHERE® Demonstrates 35% Reduction in the Risk of Disease Progression or Death Versus Chemotherapy in FRα-Positive Platinum-Resistant Ovarian Cancer
WALTHAM, Mass.--(BUSINESS WIRE)--ELAHERE® Demonstrates 35% Reduction in the Risk of Disease Progression or Death Versus Chemotherapy in FRα-Positive Platinum-Resistant Ovarian Cancer more » -
Promising Data for Investigational Innovative Bispecific Ivonescimab Featured at ASCO 2023
MENLO PARK, Calif.--(BUSINESS WIRE)--Promising Data Supporting Summit's Phase III Clinical Trials for Ivonescimab Featured at ASCO 2023. more »